Toja E, Parini C, Bonetti C, Hunt P, Fortin M, Barzaghi F, Cesana R, Maggioni A, Nencioni A, Galliani G
Chemistry Department, Roussel Pharma S.p.A., Milan, Italy.
Arzneimittelforschung. 1994 Apr;44(4):501-9.
A series of 1-arylsulfonylpyrrolidin-2-ones (and 2-thiones), 1-aryl sulfonylpiperidin-2-ones (and 2-thiones) and 1-arylsulfonyl hexahydro-2H-azepin-2-one were synthesized and submitted to a battery of binding assays. The compounds showed little or no affinity for the receptors tested other than muscarinic receptors labelled either with [3H]pirenzepine or with [3H]quinuclidinyl benzilate. When tested in the isolated guinea pig ileum, they antagonized the contractions induced by acetylcholine and behaved as competitive muscarinic antagonists. After parenteral administration in mice, most compounds inhibited carbachol-induced diarrhoea but were less effective in counteracting salivation and lacrimation and showed little or no mydriatic action, thus displaying selectivity at the intestinal level. The reference drugs tested, atropine, butyl scopolamine and cimetropium bromide were far less selective. maximal in vivo activity was obtained by introducing diethylamino or 1-piperidino or 1-hexahydroazepinyl groups in the 4-position of the phenyl ring while the enlargement of a 5- to a 6-membered lactam ring or its conversion into a thiolactam had a less marked effect. The most interesting compounds were further evaluated for their ability to antagonize carbachol-induced colonic hypermotility in the rat and arecoline-induced analgesia in mice. The effect on gastric acid secretion in the rat was also investigated. The overall in vivo data showed that compounds 14, 15, 26 and 27, i.e. those bearing a 1-hexahydroazepinyl group in the 4-position of the phenyl ring, were the most potent and selective compounds.(ABSTRACT TRUNCATED AT 250 WORDS)
合成了一系列1-芳基磺酰基吡咯烷-2-酮(及2-硫酮)、1-芳基磺酰基哌啶-2-酮(及2-硫酮)和1-芳基磺酰基六氢-2H-氮杂卓-2-酮,并对其进行了一系列结合试验。除了用[³H]哌仑西平或[³H]奎宁环基苯甲酸酯标记的毒蕈碱受体外,这些化合物对所测试的其他受体几乎没有或没有亲和力。在离体豚鼠回肠中进行测试时,它们拮抗乙酰胆碱诱导产生的收缩,表现为竞争性毒蕈碱拮抗剂。在小鼠经肠胃外给药后,大多数化合物抑制卡巴胆碱诱导的腹泻,但在对抗唾液分泌和流泪方面效果较差,并且几乎没有或没有散瞳作用,因此在肠道水平上表现出选择性。所测试的参比药物阿托品、丁基东莨菪碱和溴化西托溴铵的选择性远不如这些化合物。通过在苯环的4-位引入二乙氨基、1-哌啶基或1-六氢氮杂环庚基可获得最大的体内活性,而将5元内酰胺环扩大为6元内酰胺环或转化为硫内酰胺的效果则不太明显。对最有趣的化合物进一步评估了它们拮抗大鼠中卡巴胆碱诱导的结肠运动亢进和小鼠中槟榔碱诱导的镇痛的能力。还研究了它们对大鼠胃酸分泌的影响。总体体内数据表明,化合物14、15、26和27,即那些在苯环4-位带有1-六氢氮杂环庚基的化合物,是最有效和最具选择性的化合物。(摘要截选至250词)